Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Blueprint Medicines - Chart Of The Day

|Includes: Blueprint Medicines (BPMC)

Wall Street analysts issued 6 buy recommendations

Advanced 8 time and up 11.08% in the last month

Gained 153.72% in the last year

The Chart of the Day belongs to Blueprint Medicines (BPMC).  I found the oncology stock by using Barchart to sort today's All Time High list first by the highest Weighted Alpha then for technical buy signals of 80% or more.  Since the Trend Spotter signaled a buy on 2/27 the stock gained 25.96%.

Blueprint Medicines Corp is an oncology company which is engaged in developing kinase inhibitors for genomically defined cancer subsets. Blueprint Medicines Corp is based in Cambridge, MA.

The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the web site when you read this report.

Barchart technical indicators:

  • 96% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 8 new highs and up 11.08% in the last month
  • Relative Strength Index 63.60%
  • Technical support level at 45.48
  • Recently traded at 46.00 with a 50 day moving average of 25.96

Fundamental factors:

  • Market Cap $1.79 billion
  • Revenue expected to shrink in the short term
  • Earnings estimated to be at a loss in the short term
  • This is a stock that is expected to be developing a good pipeline of products in the future
  • Despite the lack of short term returns Wall Street analysts issued 4 strong buy and 2 buy recommendation for the stock